黑料网

Journal of Pharmacokinetics & Experimental Therapeutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Pharmacokinet Exp Ther,

Deciphering the Dynamics: Exploring Etanercept Pharmacokinetics

Elizabeth De Maggot*
Department of Pharmacology, University of Michigan, U.S.A
*Corresponding Author : Elizabeth De Maggot, Department of Pharmacology, University of Michigan, U.S.A, Email: elizabethmaggot@umich.edu

Received Date: Feb 01, 2024 / Accepted Date: Feb 28, 2024 / Published Date: Feb 28, 2024

Abstract

Etanercept is administered via subcutaneous injection, with gradual absorption into the bloodstream and peak serum concentrations achieved within 72 hours. Its distribution is primarily limited to the intravascular compartment, with preferential localization in inflamed tissues. Unlike small molecule drugs, etanercept undergoes proteolytic degradation by endogenous enzymes, leading to predictable kinetics and minimal potential for drug-drug interactions related to metabolism. This abstract provides a concise overview of etanercept pharmacokinetics, unraveling its Absorption, Distribution, Metabolism, and Excretion (ADME) processes. Etanercept is administered via subcutaneous injection, with gradual absorption into the bloodstream and peak serum concentrations achieved within 72 hours. Its distribution is primarily limited to the intravascular compartment, with preferential localization in inflamed tissues. Unlike small molecule drugs, etanercept undergoes proteolytic degradation by endogenous enzymes, leading to predictable kinetics and minimal potential for drug-drug interactions related to metabolism.

Citation: Elizabeth D (2024) Deciphering the Dynamics: Exploring EtanerceptPharmacokinetics. J Pharmacokinet Exp Ther 8: 223.

Copyright: © 2024 Elizabeth D. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top